The prevalence and clinical course of sedative-hypnotic abuse and dependence in a large cohort.
- Authors
- Schuckit, Marc A; Smith, Tom L; Kramer, John; Danko, George; Volpe, Fredric R
- Year
- 2002
- Journal
- The American journal of drug and alcohol abuse
- PMID
- 11853136
- DOI
- 10.1081/ada-120001282
Relatively little is known about the prevalence and clinical characteristics of dependence on sedative-hypnotics, and almost nothing has been published regarding abuse. This report relates information on Diagnostic and Statistical Manual of the American Psychiatric Association (DSM-IIIR) sedative-hypnotic use disorders among subjects from the Collaborative Study on the Genetics of Alcoholism (COGA). A standardized interview was used to generate data on 407 men and women in Group 1 with sedative-hypnotic dependence (4.4% of the COGA sample), 34 in Group 2 with abuse (0.4%), and 3,426 comparison subjects in Group 3 with alcohol dependence in the absence of a sedative-hypnotic use disorder (36.7%). The remaining COGA subjects (48.5%) were not included as they had neither alcohol nor sedative-hypnotic dependence or abuse. Those with sedative-hypnotic abuse or dependence were more likely to be Caucasian individuals with abuse or dependence on marijuana, cocaine, amphetamines, or opioids. Subjects in Groups 1 and 2 were also more likely to have histories of independent major depressive and panic disorders, as well as substance-induced mood disorders. Those with dependence, compared to abuse, were likely to be women, reported staying intoxicated for a day or more, but noted less abuse of opioids or amphetamines, although Group 2 members also had high rates of difficulties with sedative-hypnotics. These results highlight notable rates of sedative-hypnotic dependence in the COGA families, and indicate that while sedative-hypnotic abuse does occur, and while the clinical course can involve relatively serious problems, it is less common than dependence.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. | 2009 | 18775607 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Risk factors for unnatural death: Fatal accidental intoxication, undetermined intent and suicide: Register follow-up in a criminal justice population with substance use problems. | Olsson MO et al. | — | 2016 | → |
| Impact of hypnotics use on daytime function and factors associated with usage by female shift work nurses. | Futenma K et al. | — | 2015 | → |
| The Use of Hypnotics and Mortality--A Population-Based Retrospective Cohort Study. | Lan TY et al. | — | 2015 | → |
| Probability and predictors of remission from life-time prescription drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. | Blanco C et al. | — | 2013 | → |
| The more the merrier? Working towards multidisciplinary management of obstructive sleep apnea and comorbid insomnia. | Ong JC et al. | — | 2013 | → |
| Correlations among insomnia symptoms, sleep medication use and depressive symptoms. | Komada Y et al. | — | 2011 | → |
| Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. | Ford JD et al. | — | 2009 | → |
| Brief intervention in general hospital for problematic prescription drug use: 12-month outcome. | Otto C et al. | — | 2009 | → |
| Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients. | Zahradnik A et al. | — | 2009 | → |
| Panic disorder, alcohol and substance abuse, and benzodiazepine prescription. | Sansone RA et al. | — | 2005 | → |